RiverVest Venture Partners® invests exclusively in life science innovation. Our expertise is identifying, founding and actively incubating promising life science companies, particularly in the medical device and biopharmaceutical industries.

RiverVest also invests in select later-stage venture opportunities to diversify risk and maximize portfolio returns. Since its inception in September 2000, RiverVest has raised two investment funds with total committed capital of $164 million, and supported more than 20 innovative life science companies.

	Accumetrics, Inc., San Diego, CA Medical diagnostics company commercializing the VerifyNow® System for the assessment of platelet function in patients taking antiplatelet therapies.	PRIVATE
	CGI Pharmaceuticals, Inc., Branford, CT Biopharmaceutical company developing novel therapeutics targeting protein kinases for cancer and autoimmune/inflammatory diseases.	PRIVATE
	Cabrellis Pharmaceuticals Corporation, San Diego, CA Acquired by Pharmion Corporation (PHRM) Specialty pharmaceutical company developing therapies for the treatment of cancer.	ACQUIRED
	Calypso Medical Technologies, Inc., Seattle, WA Medical device company commercializing a proprietary localization system to improve accuracy and management of external beam radiation therapy.	PRIVATE
	Cameron Health, Inc., San Clemente, CA Medical device company developing a next-generation implantable defibrillator that is easier to implant and does not require leads that attach to the heart.	PRIVATE
	Centerre Healthcare Corporation, Brentwood, TN Healthcare services company developing and operating inpatient rehabilitation facilities in partnership with leading acute care hospitals.	PRIVATE
	Conforma Therapeutics Corporation, San Diego, CA Acquired by Biogen Idec (BIIB) Biotechnology company developing drugs that target a novel pathway, HSP90 inhibition, for the treatment of cancer.	ACQUIRED
	CyDex Pharmaceuticals, Inc., Overland, KS Specialty pharmaceutical company commercializing a proprietary technology that improves drug solubility.	PRIVATE
	Excaliard Pharmaceuticals, Inc., Carlsbad, CA Biopharmaceutical company focused on developing drugs for the local treatment of fibrosis, including skin scarring.	PRIVATE
	IDev Technologies, Inc., Houston, TX Medical device company commercializing a novel stent for the treatment of peripheral vascular disease.	PRIVATE
	Kaperio, Inc., St. Louis, MO Seed-stage biopharmaceutical company focused on cardiovascular disease.	PRIVATE
	Kereos, Inc., St. Louis, MO Biotechnology company developing site-targeted drugs and molecular imaging agents for cancer and cardiovascular disease.	PRIVATE
	Luminous Medical, Inc., Carlsbad, CA Medical device company developing an innovative automated glucose measurement system to facilitate tight glycemic control in hospital settings.	PRIVATE
	Lutonix, Inc., Minneapolis, MN Medical device company developing drug-coated balloon catheters for the treatment of vascular disease.	PRIVATE
	MacroGenics, Inc., Rockville, MD Leading antibody therapeutics company with a focus on autoimmune diseases and cancer.	PRIVATE
	Mpex Pharmaceuticals, San Diego, CA Biopharmaceutical company developing an inhaled antibiotic for the treatment of cystic fibrosis and chronic obstructive pulmonary disease, and new therapies to combat the growing issue of antibiotic resistance.	PRIVATE
	Otonomy, Inc., San Diego, CA Biopharmaceutical company developing novel drug therapies for disorders of the inner and middle ear.	PRIVATE
	Salient Surgical Technologies, Inc., Portsmouth, NH (Formerly TissueLink) Medical device company commercializing innovative radio-frequency electrosurgical instruments for orthopedic, spine, and general surgery.	PRIVATE
	Tryton Medical, Inc., Durham, NC Medical device company commercializing novel stent systems for the treatment of bifurcation lesions in coronary arteries.	PRIVATE
	Velocimed, LLC, Minneapolis, MN Acquired by St. Jude Medical, Inc. (STJ) Leading medical device company developing endovascular and cardiology-related technologies.	ACQUIRED
	Xcyte Therapies, Inc., Seattle, WA IPO, then acquired by Cyclacel Pharmaceuticals (CYCC) Biotechnology company developing novel cell-based immunotherapeutic treatments for cancer and infectious disease.	IPO
	Xoft, Inc., Fremont, CA Medical device company commercializing electronic, miniaturized x-ray technology for use in radiation oncology.	PRIVATE